Related Experiment Video
Updated: Jun 9, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Fast-Track Aspirin Odyssey: ICU Chronicles
Malay Rathod1, Shivani Modi2, Sai Gaddameedi1
1Internal Medicine, Monmouth Medical Center, Rutgers University, Long Branch, USA.
Insights
Rapid aspirin desensitization enables crucial post-stent treatment for patients with aspirin hypersensitivity. This approach facilitates necessary procedures like percutaneous coronary intervention (PCI) and stent placement in critical coronary artery disease cases.
Area of Science:
- Cardiology
- Allergology
- Pharmacology
Background:
- Aspirin is vital for managing coronary artery disease (CAD), particularly after procedures like percutaneous coronary intervention (PCI) and stent placement.
- Aspirin hypersensitivity presents a clinical challenge, necessitating alternative treatments like clopidogrel or desensitization protocols.
- Traditional aspirin desensitization protocols can be lengthy and impractical in emergent situations requiring immediate intervention.
Observation:
- A patient with coronary artery stenosis requiring stent placement reported a severe aspirin allergy.
- Standard aspirin desensitization protocols were deemed impractical due to the emergent nature of the condition.
- A rapid aspirin desensitization protocol was successfully administered in the Intensive Care Unit (ICU) within a short timeframe.
Findings:
- The rapid desensitization allowed the patient to undergo PCI and subsequent stent placement in the right coronary artery (RCA).
- The patient tolerated dual antiplatelet therapy (DAPT) with aspirin and clopidogrel post-procedure.
- Successful rapid desensitization enabled essential treatment for CAD in an aspirin-allergic patient.
Implications:
- Rapid aspirin desensitization offers a viable and time-efficient alternative for managing aspirin-allergic patients needing urgent cardiovascular interventions.
- This approach expands treatment options for patients with CAD and aspirin hypersensitivity, improving outcomes.
- Facilitates adherence to long-term aspirin therapy post-stent placement, crucial for preventing stent thrombosis.
Abstract:
Aspirin is used in patients with coronary artery disease essential in both acute and chronic phases of treatment, especially post-catheterization and post-coronary artery stent placement. Some patients have sensitivity to aspirin. Hypersensitivity reaction symptoms include itchy and watery eyes, itchy rash, worsening asthma, wheezing to fatal angioedema, and anaphylaxis. In such cases, clopidogrel can be used instead of aspirin if it is necessary to avoid the use of aspirin. Alternatively, we can try desensitization to aspirin. In aspirin desensitization, incremental doses of aspirin are provided at fixed time intervals. It usually lasts between one and three days. These protocols are often impractical in emergent conditions, especially in conditions where percutaneous coronary intervention (PCI) reveals coronary artery stenosis requiring stent placement. Post-stent placement long-term treatment with aspirin is needed. This has led to limited application in clinical practice despite the potential benefits. We present a case of a patient who presented to us with complaints of shortness of breath and intermittent chest pain. A thorough evaluation was conducted, including cardiac catheterization, which revealed a 70% blockage in the right coronary artery (RCA) and a 65% blockage in the left anterior descending (LAD) artery, necessitating stent placement. The patient reported a severe allergy to aspirin, requiring aspirin desensitization. Rapid aspirin desensitization was successfully performed in the ICU, taking two hours and 15 minutes. The patient underwent PCI and stent placement in the RCA the following day. She is currently on dual antiplatelet therapy with aspirin and clopidogrel and has scheduled follow-ups with both a cardiologist and an allergist.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary SyndromeI: Introduction
Acute Coronary Syndrome III: Diagnostic studies
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Coronary Artery Disease V: Surgical Management

